These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 32833771)

  • 21. What's next now that the WHO has declared a COVID-19 pandemic?
    Vogel L
    CMAJ; 2020 Mar; 192(13):E349-E350. PubMed ID: 32392490
    [No Abstract]   [Full Text] [Related]  

  • 22. Sample Pooling as a Strategy to Detect Community Transmission of SARS-CoV-2.
    Hogan CA; Sahoo MK; Pinsky BA
    JAMA; 2020 May; 323(19):1967-1969. PubMed ID: 32250394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Saliva as an Alternate Specimen Source for Detection of SARS-CoV-2 in Symptomatic Patients Using Cepheid Xpert Xpress SARS-CoV-2.
    McCormick-Baw C; Morgan K; Gaffney D; Cazares Y; Jaworski K; Byrd A; Molberg K; Cavuoti D
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32414838
    [No Abstract]   [Full Text] [Related]  

  • 24. Five-minute point-of-care testing for SARS-CoV-2: Not there yet.
    Hogan CA; Sahoo MK; Huang C; Garamani N; Stevens B; Zehnder J; Pinsky BA
    J Clin Virol; 2020 Jul; 128():104410. PubMed ID: 32403009
    [No Abstract]   [Full Text] [Related]  

  • 25. [COVID-19 and Pulmonology: New Challenges and Opportunities].
    Clérigo V; Duarte P
    Acta Med Port; 2020 Oct; 33(10):710. PubMed ID: 32877327
    [No Abstract]   [Full Text] [Related]  

  • 26. The First Quarter of SARS-CoV-2 Testing: the University of Washington Medicine Experience.
    Greninger AL; Jerome KR
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32703897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Which sampling method for the upper respiratory tract specimen should be taken to diagnose patient with COVID-19?].
    Ye B; Fan C; Pan Y; Ding R; Hu HX; Xiang ML
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Jun; 55(6):583-588. PubMed ID: 32166939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drive-Through Testing: A Unique, Efficient Method of Collecting Large Volume of Specimens During the SARS-CoV-2 (COVID-19) Pandemic.
    Shah A; Challener D; Tande AJ; Mahmood M; O'Horo JC; Berbari E; Crane SJ
    Mayo Clin Proc; 2020 Jul; 95(7):1420-1425. PubMed ID: 32448589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sample collection and stabilization from saliva samples for SARS-CoV-2 detection by qPCR.
    Biotechniques; 2020 Sep; 69(3):237. PubMed ID: 32929994
    [No Abstract]   [Full Text] [Related]  

  • 30. DNA nanoscaffold-based SARS-CoV-2 detection for COVID-19 diagnosis.
    Jiao J; Duan C; Xue L; Liu Y; Sun W; Xiang Y
    Biosens Bioelectron; 2020 Nov; 167():112479. PubMed ID: 32763826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evolving reporting criteria of COVID-19 in Taiwan during the epidemic.
    Huang YC; Lee PI; Hsueh PR
    J Microbiol Immunol Infect; 2020 Jun; 53(3):413-418. PubMed ID: 32224117
    [No Abstract]   [Full Text] [Related]  

  • 32. Disposition of patients with coronavirus disease 2019 (COVID-19) whose respiratory specimens remain positive for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) by polymerase chain reaction assay (PCR).
    Mermel LA
    Infect Control Hosp Epidemiol; 2020 Nov; 41(11):1326-1327. PubMed ID: 32517833
    [No Abstract]   [Full Text] [Related]  

  • 33. Saliva Alternative to Upper Respiratory Swabs for SARS-CoV-2 Diagnosis.
    Byrne RL; Kay GA; Kontogianni K; Aljayyoussi G; Brown L; Collins AM; Cuevas LE; Ferreira DM; Fraser AJ; Garrod G; Hill H; Hughes GL; Menzies S; Mitsi E; Owen SI; Patterson EI; Williams CT; Hyder-Wright A; Adams ER; Cubas-Atienzar AI
    Emerg Infect Dis; 2020 Nov; 26(11):2770-2771. PubMed ID: 32917294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A COVID-19 Patient with Repeatedly Undetectable SARS-CoV-2 Antibodies.
    Goetz L; Yang J; Greene W; Zhu Y
    J Appl Lab Med; 2020 Nov; 5(6):1401-1405. PubMed ID: 32745181
    [No Abstract]   [Full Text] [Related]  

  • 35. Re-emergence of SARS-CoV2 in a discharged COVID-19 case.
    Zhou M; Li Q; Cao L; Liu Y; Zha Y; Xie H; Zeng M; Shi X; Gao Y; Xie L; Luo M; Zeng Y
    J Microbiol Immunol Infect; 2020 Jun; 53(3):501-502. PubMed ID: 32303482
    [No Abstract]   [Full Text] [Related]  

  • 36. The Challenges of Expanding Rapid Tests to Curb COVID-19.
    Rubin R
    JAMA; 2020 Nov; 324(18):1813-1815. PubMed ID: 33084882
    [No Abstract]   [Full Text] [Related]  

  • 37. Approach to Chilblains During the COVID-19 Pandemic [Formula: see text].
    Ladha MA; Luca N; Constantinescu C; Naert K; Ramien ML
    J Cutan Med Surg; 2020; 24(5):504-517. PubMed ID: 32741218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The utility of beta-2-microglobulin testing as a human cellular control in COVID-19 testing.
    Davies E; Whitfield T; Machin N; Ahmad S
    J Clin Virol; 2020 Aug; 129():104449. PubMed ID: 32504943
    [No Abstract]   [Full Text] [Related]  

  • 39. COVID 19 diagnostic multiplicity and its role in community surveillance and control.
    Tripathi SC; Deshmukh V; Patil A; Tripathy JP
    Infez Med; 2020 Jun; 28(suppl 1):18-28. PubMed ID: 32532934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Test Agreement between Roche Cobas 6800 and Cepheid GeneXpert Xpress SARS-CoV-2 Assays at High Cycle Threshold Ranges.
    Broder K; Babiker A; Myers C; White T; Jones H; Cardella J; Burd EM; Hill CE; Kraft CS
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32444354
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.